» Articles » PMID: 29930949

Epidemiology and Natural History of Airway Infections in Non-cystic Fibrosis Bronchiectasis

Overview
Journal ERJ Open Res
Specialty Pulmonary Medicine
Date 2018 Jun 23
PMID 29930949
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The natural history and epidemiology of infections in non-cystic fibrosis (non-CF) bronchiectasis is not well understood. As such it was our intention to determine the evolution of airway infection and the transmission potential of in patients with non-CF bronchiectasis. A longitudinal cohort study was conducted from 1986-2011 using a biobank of prospectively collected isolates from patients with non-CF bronchiectasis. Patients included were ≥18 years old and had ≥2 positive cultures over a minimum 6-month period. All isolates obtained at first and most recent clinical encounters, as well as during exacerbations, that were morphologically distinct on MacConkey agar were genotyped by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). A total of 203 isolates from 39 patients were analysed. These were compared to a large collection of globally epidemic and local CF strains, as well as non-CF isolates. We identified four patterns of infection in non-CF bronchiectasis including: 1) persistence of a single strain (n=26; 67%); 2) strain displacement (n=8; 20%); 3) temporary disruption (n=3; 8%); and 4) chaotic airway infection (n=2; 5%). Patterns of infection were not significant predictors of rates of lung function decline or progression to end-stage disease and acquisition of new strains did not associate with the occurrence of exacerbations. Rarely, non-CF bronchiectasis strains with similar pulsotypes were observed in CF and non-CF controls, but no CF epidemic strains were observed. While rare shared strains were observed in non-CF bronchiectasis, whole-genome sequencing refuted patient-patient transmission. We observed a higher incidence of strain-displacement in our patient cohort compared to those observed in CF studies, although this did not impact on outcomes.

Citing Articles

Sputum metagenomics of people with bronchiectasis.

Rosenboom I, Thavarasa A, Richardson H, Long M, Wiehlmann L, Davenport C ERJ Open Res. 2024; 10(2).

PMID: 38444657 PMC: 10910388. DOI: 10.1183/23120541.01008-2023.


Can microbiologists and infectious diseases physicians contribute to the management of bronchiectasis? A view from Down Under.

Grimwood K, Laupland K J Assoc Med Microbiol Infect Dis Can. 2023; 8(3):161-164.

PMID: 38058497 PMC: 10697096. DOI: 10.3138/jammi-2023-07-05.


Inhaled Antibiotics in Non-cystic Fibrosis Bronchiectasis (NCFB): A Systematic Review of Efficacy and Limitations in Adult Patients.

Amjad Z, Abaza A, Vasavada A, Sadhu A, Valencia C, Fatima H Cureus. 2022; 14(10):e30660.

PMID: 36439573 PMC: 9685586. DOI: 10.7759/cureus.30660.


Affects Airway Epithelial Response and Barrier Function During Rhinovirus Infection.

Endres A, Hugel C, Boland H, Hogardt M, Schubert R, Jonigk D Front Cell Infect Microbiol. 2022; 12:846828.

PMID: 35265536 PMC: 8899922. DOI: 10.3389/fcimb.2022.846828.


The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update.

Reynolds D, Kollef M Drugs. 2021; 81(18):2117-2131.

PMID: 34743315 PMC: 8572145. DOI: 10.1007/s40265-021-01635-6.


References
1.
Workentine M, Surette M, Bernier S . Draft Genome Sequence of Burkholderia dolosa PC543 Isolated from Cystic Fibrosis Airways. Genome Announc. 2014; 2(1). PMC: 3924365. DOI: 10.1128/genomeA.00043-14. View

2.
Waters V, Zlosnik J, Yau Y, Speert D, Aaron S, Guttman D . Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis. 2012; 31(12):3341-50. DOI: 10.1007/s10096-012-1701-z. View

3.
Somayaji R, Lam J, Surette M, Waddell B, Rabin H, Sibley C . Long-term clinical outcomes of 'Prairie Epidemic Strain' infection in adults with cystic fibrosis. Thorax. 2016; 72(4):333-339. DOI: 10.1136/thoraxjnl-2015-208083. View

4.
Romling U, Kader A, Sriramulu D, Simm R, Kronvall G . Worldwide distribution of Pseudomonas aeruginosa clone C strains in the aquatic environment and cystic fibrosis patients. Environ Microbiol. 2005; 7(7):1029-38. DOI: 10.1111/j.1462-2920.2005.00780.x. View

5.
Mitchelmore P, Randall J, Bull M, Moore K, ONeill P, Paszkiewicz K . Molecular epidemiology of in an unsegregated bronchiectasis cohort sharing hospital facilities with a cystic fibrosis cohort. Thorax. 2017; . DOI: 10.1136/thoraxjnl-2016-209889. View